An Open-Label Long Term Safety Study of SD-809 ER in Subjects with Chorea Associated with Huntington Disease (ARC-HD)
J
Joanne Wojcieszek
Primary Investigator
J
Jessica MacLean
Primary Investigator
Not Recruiting
18 years - 100 years
All
Phase
N/A
1 Location
Brief description of study
This study will look at what the body does to the study drug and if the drug lessens chorea in Huntington's Disease.
Detailed description of study
This study will look at what the body does to the study drug and if the drug lessens chorea in Huntington's Disease.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Huntington Disease,Chorea
-
Age: 18 years - 100 years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 1405196617
